Dr. Samaneh Asgari is a  Professor of Epidemiology at the Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. She holds a PhD in Epidemiology and an MSc in Biostatistics, and her main research interests include diabetes, metabolic disorders, prediction model development and validation, risk estimation, and advanced statistical analysis. Her research is particularly focused on developing and validating prediction models for diabetes and cardiovascular disease (CVD) risk. Over the years, she has collaborated on numerous national and international research projects, building extensive experience in longitudinal and survival analysis, survey data analysis, trend, forecasting, and cascade analysis. She has worked on population-based and clinical research projects aimed at improving early detection, prevention,  and management of diabetes and related chronic diseases. She has authored

Dr. Ahdy W. Helmy is an endocrinologist in Indianapolis, Indiana and is affiliated with Richard L. Roudebush Veterans Affairs Medical Center. He received his medical degree from University of Alexandria Faculty of Medicine and has been in practice for more than 20 years.Dr. Ahdy W. Helmy is an endocrinologist in Indianapolis, Indiana and is affiliated with Richard L. Roudebush Veterans Affairs Medical Center. He received his medical degree from University of Alexandria Faculty of Medicine and has been in practice for more than 20 years.

Prof. Vladimir N. Anisimov is a renowned researcher in gerontology, oncology, and aging studies. He served as Head of the Department of Carcinogenesis and Oncogerontology at the N.N. Petrov National Medical Research Center of Oncology, Russia, and as President of the Gerontology Society at the Russian Academy of Sciences. He is currently the Editor-in-Chief of Advances in Gerontology and serves on the editorial boards of several international journals. Prof. Anisimov has received numerous prestigious research grants and awards and has authored over 500 peer-reviewed publications in leading journals. His research focuses on aging, cancer mechanisms, IGF-1 signaling, metformin as a geroprotector, and the role of melatonin and circadian rhythms in aging and cancer.

Prof. David M. Nathan is a leading expert in diabetes care and metabolic disorders. He serves as Professor of Medicine at Harvard Medical School and is internationally recognized for his contributions to diabetes prevention, glycemic management, and clinical research.

Prof. Gundu H. R. Rao is a distinguished researcher and innovator in thrombosis, stroke, and biomedical sciences. He serves on the boards of several healthcare and medical technology organizations in India and the USA and is affiliated with the University of Minnesota Medical School. With over 300 scientific publications, his research focuses on thrombosis, stroke, biocompatibility, and cardiovascular health. He has also worked extensively with leading global medical device companies and international research institutions.

Prof. Jennifer Green is a highly respected expert in endocrinology and cardiovascular outcomes in diabetes, with extensive experience in clinical research and patient-centered diabetes care. She serves as Professor of Medicine at Duke University School of Medicine, USA, and has contributed significantly to large-scale international clinical trials evaluating the safety and effectiveness of diabetes therapies. Her research interests include cardiovascular complications in diabetes, preventive endocrinology, metabolic disorders, and improving long-term outcomes for patients with chronic endocrine conditions. Prof. Green has authored numerous peer-reviewed scientific publications and is widely recognized for her contributions to evidence-based diabetes management, innovative therapeutic strategies, and advancements in endocrine healthcare.